WOOJUNG BIO, Inc. (KOSDAQ:215380)
2,450.00
-255.00 (-9.43%)
At close: Apr 2, 2026
WOOJUNG BIO Market Cap
WOOJUNG BIO has a market cap or net worth of 41.23 billion as of April 2, 2026. Its market cap has increased by 54.09% in one year.
Market Cap
41.23B
Enterprise Value
87.64B
Revenue
37.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,450.00
Market Cap Chart
Since April 20, 2017, WOOJUNG BIO's market cap has decreased from 44.42B to 41.23B, a decrease of -7.17%. That is a compound annual growth rate of -0.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 41.23B | 39.13% |
| Dec 30, 2025 | 29.64B | 3.59% |
| Dec 30, 2024 | 28.61B | 5.65% |
| Dec 28, 2023 | 27.08B | -29.98% |
| Dec 29, 2022 | 38.68B | -52.23% |
| Dec 30, 2021 | 80.97B | -29.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 605.13B |
| DreamCIS | 114.90B |
| HLB bioStep | 103.81B |
| P&K Skin Research Center | 59.79B |
| C&R Research | 45.69B |
| DT&CRO CO. | 42.12B |
| SLS BIO | 26.89B |
| BioInfra | 19.26B |